Roflumilast Cream 0.3%: Clinical Trials

3 trials of Roflumilast Cream 0.3%, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2
Phase 21Completed 1

Follow Roflumilast Cream 0.3%: new trials by email Literature Review of Roflumilast Cream 0.3% trials Research Report on Roflumilast Cream 0.3%

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study
Roflumilast Cream 0.3%, Vehicle cream - Plaque Psoriasis
Phase 3CompletedHangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1902024-11-142026-07-06
Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis
roflumilast cream 0.3%, Zoryve, Placebo - Plaque Psoriasis
Phase 3CompletedPadagis LLC4162023-02-072026-08-26
The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis
Roflumilast Cream 0.3%, Roflumilast Cream 0.15%, Vehicle Cream - Plaque Psoriasis
Phase 2CompletedArcutis Biotherapeutics, Inc.3312018-09-212022-09-02

Sponsors

Arcutis Biotherapeutics, Inc. (1)  ·  Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (1)  ·  Padagis LLC (1)

Countries

United States (2)  ·  Canada (1)  ·  China (1)

Top investigators

David Berk, MD (1)

Results publications

PMID 32668113, PMID 36370336